Cardiovascular endocrinology is an interdisciplinary field that explores the intricate connections between the endocrine system and cardiovascular health. The endocrine system, consisting of glands that produce hormones, plays a crucial role in regulating various physiological processes, including those related to the cardiovascular system. Hormones such as insulin, cortisol, and thyroid hormones influence blood pressure, heart rate, and metabolism. Disorders of the endocrine system, such as diabetes and thyroid dysfunction, can have profound effects on cardiovascular health and increase the risk of developing heart diseases. Cardiovascular endocrinologists focus on understanding these complex interactions, investigating how hormonal imbalances contribute to atherosclerosis, hypertension, and other cardiovascular conditions. The field aims to identify novel therapeutic targets and interventions that address both endocrine and cardiovascular components, promoting holistic approaches to the prevention and management of cardiovascular diseases.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States